{"id":"losartan-drug","safety":{"commonSideEffects":[{"rate":"7-10","effect":"Dizziness"},{"rate":"3-5","effect":"Fatigue"},{"rate":"2-4","effect":"Hyperkalemia"},{"rate":"1-3","effect":"Cough"},{"rate":"1-3","effect":"Hypotension"},{"rate":"1-2","effect":"Headache"}]},"_chembl":{"chemblId":"CHEMBL382821","moleculeType":"Small molecule","molecularWeight":"467.92"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Losartan is an angiotensin II receptor antagonist (ARB) that selectively blocks the AT1 receptor subtype. By preventing angiotensin II from binding to these receptors, it causes vasodilation, reduces aldosterone secretion, and decreases sodium and water retention, leading to lower blood pressure and reduced cardiac workload.","oneSentence":"Losartan blocks angiotensin II receptors on blood vessels and tissues, preventing vasoconstriction and reducing blood pressure.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:53:03.860Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hypertension"},{"name":"Heart failure with reduced ejection fraction"},{"name":"Diabetic nephropathy in patients with type 2 diabetes"},{"name":"Post-myocardial infarction"}]},"trialDetails":[{"nctId":"NCT07300670","phase":"PHASE1","title":"The Effect of Losartan on Cephalexin","status":"RECRUITING","sponsor":"Aleksi Tornio","startDate":"2026-03-04","conditions":"Possible Interaction Between Losartan and Cephalexin, Healthy","enrollment":12},{"nctId":"NCT05012631","phase":"PHASE2","title":"Losartan for Diffuse Myocardial Fibrosis in Sickle Cell Disease","status":"RECRUITING","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2021-09-01","conditions":"Sickle Cell Disease, Diffuse Myocardial Fibrosis","enrollment":24},{"nctId":"NCT06211335","phase":"PHASE1","title":"Losartan, Pembrolizumab and Stereotactic Body Radiation Therapy for the Treatment of Patients With Locally Recurrent, Refractory or Oligometastatic Head and Neck Squamous Cell Carcinoma","status":"RECRUITING","sponsor":"University of California, Davis","startDate":"2023-12-07","conditions":"Locally Recurrent Head and Neck Squamous Cell Carcinoma, Metastatic Head and Neck Squamous Cell Carcinoma, Refractory Head and Neck Squamous Cell Carcinoma","enrollment":24},{"nctId":"NCT07449000","phase":"NA","title":"Losartan for Corneal Fibrosis","status":"RECRUITING","sponsor":"Universidad Autonoma de Nuevo Leon","startDate":"2026-02-12","conditions":"Corneal Scarring Fibrosis","enrollment":46},{"nctId":"NCT03417388","phase":"PHASE4","title":"Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Florida","startDate":"2018-02-09","conditions":"Coronary Artery Disease","enrollment":2476},{"nctId":"NCT06930872","phase":"PHASE1","title":"Drug Interaction Study of ZYN002 Transdermal Gel and Probe Substrates","status":"COMPLETED","sponsor":"Harmony Biosciences Management, Inc.","startDate":"2025-06-06","conditions":"Drug Interaction","enrollment":29},{"nctId":"NCT03900793","phase":"PHASE1","title":"Losartan + Sunitinib in Treatment of Osteosarcoma","status":"RECRUITING","sponsor":"University of Colorado, Denver","startDate":"2019-08-26","conditions":"Osteosarcoma","enrollment":41},{"nctId":"NCT04591210","phase":"PHASE3","title":"The COVID-RASi Trial (COVID-19)","status":"COMPLETED","sponsor":"Ottawa Heart Institute Research Corporation","startDate":"2021-01-27","conditions":"COVID-19, Cardiovascular Diseases","enrollment":372},{"nctId":"NCT06933706","phase":"PHASE2","title":"Losartan to Improve Outcomes After Multi-ligament Knee Injury","status":"RECRUITING","sponsor":"Brigham and Women's Hospital","startDate":"2025-10-01","conditions":"Multi-ligament Knee Injury","enrollment":90},{"nctId":"NCT04539808","phase":"PHASE2","title":"NeoOPTIMIZE: Early Switching of mFOLFIRINOX or Gemcitabine/Nab-Paclitaxel Before Surgery for the Treatment of Resectable, Borderline Resectable, or Locally-Advanced Unresectable Pancreatic Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"OHSU Knight Cancer Institute","startDate":"2021-05-27","conditions":"Pancreatic Adenocarcinoma, Stage 0 Pancreatic Cancer American Joint Committee on Cancer v8, Stage I Pancreatic Cancer American Joint Committee on Cancer v8","enrollment":42},{"nctId":"NCT05370599","phase":"PHASE2","title":"Hypertension in Young Adults Trial","status":"TERMINATED","sponsor":"University of California, San Francisco","startDate":"2022-04-15","conditions":"Hypertension","enrollment":36},{"nctId":"NCT07135687","phase":"PHASE4","title":"Study to Use Oral Losartan to Decrease the Risk of Postoperative Scarring Following (ACL) Reconstruction","status":"NOT_YET_RECRUITING","sponsor":"Rush University Medical Center","startDate":"2026-08","conditions":"ACL Injury, ACL Reconstruction, Scar Formation","enrollment":144},{"nctId":"NCT07265739","phase":"PHASE2","title":"Losartan and Paclitaxel in Platinum Resistant Ovarian Cancer","status":"NOT_YET_RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2026-04","conditions":"Platinum Resistant Ovarian Cancer","enrollment":27},{"nctId":"NCT05619653","phase":"PHASE3","title":"Myocardial Protection in Patients With Post-acute Inflammatory Cardiac Involvement Due to COVID-19","status":"ACTIVE_NOT_RECRUITING","sponsor":"Valentina Puentmann","startDate":"2022-12-12","conditions":"COVID-19 Associated Cardiac Involvement, Remodeling, Left Ventricle, Remodeling, Vascular","enrollment":279},{"nctId":"NCT07262710","phase":"","title":"Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers With Post-Stroke Pneumonia: A Real-World Retrospective Cohort Study","status":"NOT_YET_RECRUITING","sponsor":"First Teaching Hospital of Tianjin University of Traditional Chinese Medicine","startDate":"2025-12-01","conditions":"Post-stroke Pneumonia","enrollment":13656},{"nctId":"NCT05077800","phase":"PHASE2","title":"FOLFIRINOX + Elraglusib + Losartan In Pancreatic Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Colin D. Weekes, M.D., PhD","startDate":"2022-03-21","conditions":"Pancreatic Adenocarcinoma, Pancreatic Adenocarcinoma Metastatic","enrollment":70},{"nctId":"NCT03435939","phase":"EARLY_PHASE1","title":"Effect of Losartan in Cystic Fibrosis (CF)-NIH Grant #133240","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Kansas Medical Center","startDate":"2022-02-15","conditions":"Cystic Fibrosis","enrollment":16},{"nctId":"NCT01199978","phase":"PHASE2","title":"Hearing Outcomes Using Fractionated Proton Radiation Therapy for Vestibular Schwannoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2011-03-08","conditions":"Vestibular Schwannoma, Acoustic Neuroma","enrollment":30},{"nctId":"NCT03563248","phase":"PHASE2","title":"Losartan and Nivolumab in Combination With FOLFIRINOX and SBRT in Localized Pancreatic Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2018-08-10","conditions":"Pancreatic Cancer","enrollment":168},{"nctId":"NCT07160361","phase":"PHASE4","title":"Exploration of Postoperative Adjuvant Therapy for HCC Patients With Positive TB","status":"NOT_YET_RECRUITING","sponsor":"Second Affiliated Hospital of Xi'an Jiaotong University","startDate":"2025-10-01","conditions":"Carcinoma, Hepatocellular","enrollment":56},{"nctId":"NCT05402397","phase":"PHASE4","title":"Losartan and Uric Acid Metabolism in Children With Proteinuric Nephropathies","status":"COMPLETED","sponsor":"Hospital General de Niños Pedro de Elizalde","startDate":"2022-07-01","conditions":"Uric Acid Nephropathy","enrollment":40},{"nctId":"NCT06796660","phase":"EARLY_PHASE1","title":"Exploring the Impact of Nephropathy Formula No. 1 on Chronic Kidney Disease Patients","status":"NOT_YET_RECRUITING","sponsor":"Liu Zhanghong","startDate":"2025-09-01","conditions":"Renal Insufficiency, Chronic","enrollment":70},{"nctId":"NCT05331144","phase":"PHASE2","title":"Impact of Intensive Treatment of SBP on Brain Perfusion, Amyloid, and Tau (IPAT Study)","status":"RECRUITING","sponsor":"Rong Zhang","startDate":"2022-10-25","conditions":"Cognitively Normal Older Adults, Hypertension, Subjective Cognitive Decline","enrollment":180},{"nctId":"NCT06150560","phase":"PHASE3","title":"A Study of Angiotensin-II Receptor Blocker on Cardiovascular Remodeling (VALUE Trial)","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2024-04-01","conditions":"Coarctation of Aorta, High Blood Pressure","enrollment":120},{"nctId":"NCT07099859","phase":"PHASE4","title":"Effect of Losartan on the Neurohumoral Axis and Ventricular Remodeling of Patients With Severe Aortic Regurgitation Undergoing Valve Surgery.","status":"RECRUITING","sponsor":"Vitor Emer Egypto Rosa","startDate":"2025-07-01","conditions":"Heart Valve Diseases, Left Ventricle Remodeling, Aortic Regurgitation Disease","enrollment":60},{"nctId":"NCT06624904","phase":"EARLY_PHASE1","title":"Losartan and Social Processing","status":"RECRUITING","sponsor":"University of Oxford","startDate":"2024-08-19","conditions":"Social Cognition","enrollment":68},{"nctId":"NCT07017023","phase":"EARLY_PHASE1","title":"Combined Blood Pressure Medication and Activity Scheduling for Low Mood","status":"RECRUITING","sponsor":"University of Oxford","startDate":"2025-07-08","conditions":"Emotional Processing, Mood","enrollment":76},{"nctId":"NCT04715568","phase":"PHASE4","title":"Secondhand Tobacco Smoke and Cardiovascular Disease","status":"RECRUITING","sponsor":"University of California, San Francisco","startDate":"2021-03-30","conditions":"Cardiovascular Diseases, Hypertension","enrollment":100},{"nctId":"NCT03295734","phase":"PHASE2","title":"ACES - ACE Inhibitors Combined With Exercise for Seniors With Hypertension","status":"COMPLETED","sponsor":"University of Alabama at Birmingham","startDate":"2018-05-29","conditions":"Hypertension, Aging, Sedentary Lifestyle","enrollment":223},{"nctId":"NCT04632589","phase":"EARLY_PHASE1","title":"Losartan for Improved Vascular Endothelial Function After Preeclampsia","status":"COMPLETED","sponsor":"Anna Stanhewicz, PhD","startDate":"2020-11-22","conditions":"Preeclampsia Postpartum","enrollment":11},{"nctId":"NCT03354143","phase":"PHASE2","title":"Hypertension, Intracranial Pulsatility and Brain Amyloid-beta Accumulation in Older Adults (HIPAC Trial)","status":"COMPLETED","sponsor":"University of Texas Southwestern Medical Center","startDate":"2018-04-10","conditions":"Hypertension","enrollment":85},{"nctId":"NCT06143566","phase":"PHASE1, PHASE2","title":"Polypill for Prevention of Cardiomyopathy","status":"RECRUITING","sponsor":"University of Texas Southwestern Medical Center","startDate":"2024-03-11","conditions":"Type 2 Diabetes, High Blood Pressure","enrollment":200},{"nctId":"NCT06636812","phase":"EARLY_PHASE1","title":"Losartan and Emotional Processing in Young People","status":"RECRUITING","sponsor":"University of Oxford","startDate":"2024-03-07","conditions":"Emotional Processing","enrollment":60},{"nctId":"NCT03519893","phase":"","title":"Bariatric Surgery and Pharmacokinetics of Losartan","status":"RECRUITING","sponsor":"Norwegian University of Science and Technology","startDate":"2016-11-02","conditions":"Obesity, Morbid","enrollment":12},{"nctId":"NCT06831864","phase":"PHASE1","title":"Heart Failure With Reduced Ejection Fraction Polypill Implementation Strategy in Sri Lanka","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2025-02-15","conditions":"Heart Failure With Reduced Ejection Fraction","enrollment":40},{"nctId":"NCT06495710","phase":"NA","title":"Arterial Stiffness and Blood Pressure","status":"RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2025-05-01","conditions":"Hypertension, Vascular Stiffness, Aging","enrollment":228},{"nctId":"NCT06364176","phase":"PHASE2","title":"Targeting Inflammation With Losartan to Improve Response to Modulator Therapy in Cystic Fibrosis.","status":"RECRUITING","sponsor":"University of Kansas Medical Center","startDate":"2024-06-03","conditions":"Cystic Fibrosis","enrollment":42},{"nctId":"NCT06135493","phase":"PHASE2","title":"Prevention of Paclitaxel-induced Peripheral Neuropathy in Breast Cancer Patients","status":"COMPLETED","sponsor":"Future University in Egypt","startDate":"2023-12-12","conditions":"Peripheral Neuropathy Due to Chemotherapy","enrollment":84},{"nctId":"NCT05637853","phase":"PHASE4","title":"Telemonitored Fast Track Medical Sequencing for Heart Failure With Reduced Ejection Fraction","status":"ACTIVE_NOT_RECRUITING","sponsor":"Göteborg University","startDate":"2022-10-22","conditions":"Heart Failure With Reduced Ejection Fraction","enrollment":60},{"nctId":"NCT04106856","phase":"PHASE1","title":"Losartan and Hypofractionated Rx After Chemo for Tx of Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer (SHAPER)","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Utah","startDate":"2019-08-08","conditions":"Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Ductal Adenocarcinoma, Locally Advanced Unresectable Pancreatic Adenocarcinoma","enrollment":22},{"nctId":"NCT04662723","phase":"PHASE4","title":"Multicentre Clinical Study to Evaluate the Effect of Personalized Therapy on Patients With Immunoglobulin A Nephropathy.","status":"RECRUITING","sponsor":"Fondazione Schena","startDate":"2023-05-01","conditions":"Glomerulonephritis, Immunoglobulin A Nephropathy","enrollment":878},{"nctId":"NCT03946514","phase":"PHASE4","title":"Efficacy and Safety of a Single-pill Fixed Combination of Sufficient Losartan/Hydrochlorothiazide in Chinese Hypertensive Patients","status":"COMPLETED","sponsor":"Shanghai Jiao Tong University School of Medicine","startDate":"2018-09-01","conditions":"Hypertension","enrollment":180},{"nctId":"NCT04927299","phase":"PHASE3","title":"Efficacy and Safety of Losartan/Chlorthalidone vs Losartan/Hydrochlorothiazide in Essential Arterial Hypertension","status":"COMPLETED","sponsor":"Laboratorios Silanes S.A. de C.V.","startDate":"2022-06-30","conditions":"Essential Arterial Hypertension","enrollment":163},{"nctId":"NCT00429364","phase":"PHASE3","title":"Comparison of Two Medications Aimed at Slowing Aortic Root Enlargement in Individuals With Marfan Syndrome","status":"COMPLETED","sponsor":"Carelon Research","startDate":"2007-01","conditions":"Marfan Syndrome","enrollment":608},{"nctId":"NCT02560805","phase":"PHASE2","title":"Role of Sympathetic Overactivity and Angiotensin II in PTSD and CV","status":"SUSPENDED","sponsor":"Emory University","startDate":"2015-10","conditions":"Stress Disorders, Post-Traumatic","enrollment":134},{"nctId":"NCT02235909","phase":"PHASE3","title":"An Efficacy and Safety Study in Children 6 to Less Than 18 Years of Age With Hypertension","status":"COMPLETED","sponsor":"Arbor Pharmaceuticals, Inc.","startDate":"2015-03-30","conditions":"Hypertension","enrollment":377},{"nctId":"NCT05498675","phase":"","title":"Effect of Sacubitril/Valsartan on Cardiac Function in Hypertensive Patients Stratified by BMI: A Real World Study","status":"RECRUITING","sponsor":"Beijing Friendship Hospital","startDate":"2021-09-01","conditions":"Sacubitril/Valsartan, Hypertension, Obesity","enrollment":180},{"nctId":"NCT05576155","phase":"EARLY_PHASE1","title":"Sex Differences in the Dilatory Response of Compound 21","status":"COMPLETED","sponsor":"Anna Stanhewicz, PhD","startDate":"2022-10-03","conditions":"Sex Differences","enrollment":26},{"nctId":"NCT05861336","phase":"PHASE2","title":"GEM+Nab-Paclitaxel Plus Losartan Followed by Stereotactic Radiotherapy for Locally Advanced Pancreatic Cancer","status":"WITHDRAWN","sponsor":"Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS","startDate":"2023-06-14","conditions":"Pancreatic Cancer","enrollment":""},{"nctId":"NCT06718062","phase":"PHASE4","title":"Non-Inferiority Study of Aliskiren vs Losartan in the Treatment of Hypertension With Hyperuricemia","status":"COMPLETED","sponsor":"Hansung University","startDate":"2021-05-01","conditions":"Hypertension,Essential, Hyperuricemia","enrollment":66},{"nctId":"NCT06693960","phase":"EARLY_PHASE1","title":"Evaluating the Pharmacokinetics of Oregano and Potential Oregano-drug Interactions Using a Drug Cocktail Approach","status":"RECRUITING","sponsor":"Washington State University","startDate":"2024-09-26","conditions":"Interaction","enrollment":16},{"nctId":"NCT06628154","phase":"EARLY_PHASE1","title":"Losartan and Emotional Learning","status":"RECRUITING","sponsor":"University of Oxford","startDate":"2024-08-14","conditions":"Emotional Processing","enrollment":60},{"nctId":"NCT03864042","phase":"PHASE1","title":"Pharmacokinetic Drug-drug Interaction Study of Encorafenib and Binimetinib on Probe Drugs in Patients With BRAF V600-mutant Melanoma or Other Advanced Solid Tumors","status":"COMPLETED","sponsor":"Pfizer","startDate":"2018-01-02","conditions":"Advanced Solid Tumors, Metastatic Melanoma","enrollment":56},{"nctId":"NCT06333522","phase":"PHASE4","title":"Losartan Use to Mitigate Arthrofibrosis Following Total Joint Arthroplasty","status":"WITHDRAWN","sponsor":"NYU Langone Health","startDate":"2024-07-01","conditions":"Arthrofibrosis of Knee","enrollment":""},{"nctId":"NCT05637216","phase":"PHASE2","title":"Losartan to Reduce Radiation Induced Fibrosis in Breast Cancer Patients","status":"RECRUITING","sponsor":"Shaw Cancer Center","startDate":"2023-08-17","conditions":"Radiation Induced Fibrosis","enrollment":40},{"nctId":"NCT01149473","phase":"PHASE1","title":"Losartan Potassium/Hydrochlorothiazide 100/25 mg Tablets in Healthy Subjects Under Non-Fasting Conditions","status":"COMPLETED","sponsor":"Teva Pharmaceuticals USA","startDate":"2004-03","conditions":"Healthy","enrollment":80},{"nctId":"NCT01124175","phase":"PHASE1","title":"Losartan 100 mg Tablet in Healthy Subjects Under Non-Fasting Conditions","status":"COMPLETED","sponsor":"Teva Pharmaceuticals USA","startDate":"2003-10","conditions":"Healthy","enrollment":80},{"nctId":"NCT00140907","phase":"PHASE4","title":"ALLOGRAFT, A Study to Evaluate the Renal Protective Effects of Losartan (0954-222)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2000-03-14","conditions":"High Blood Pressure","enrollment":367},{"nctId":"NCT00398541","phase":"PHASE3","title":"Evaluation of the Antihypertensive Effect of Hyzaar(R) and Cognitive Function of Hypertensive Patients (0954A-322)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2005-03-01","conditions":"Hypertension","enrollment":41},{"nctId":"NCT00307060","phase":"PHASE3","title":"MK0954A-264 Filter Study (0954A-264)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2004-12-01","conditions":"Mild to Severe Hypertension","enrollment":274},{"nctId":"NCT00480805","phase":"PHASE3","title":"HYZAAR vs. Ramipril for Diabetes (0954A-245)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2001-08-08","conditions":"Type 2 Diabetes Mellitus, Hypertension","enrollment":312},{"nctId":"NCT00400218","phase":"PHASE3","title":"Evaluate the Safety and Anti-Hypertensive Efficacy of Hyzaar(R) In Patients With Mild To Moderate Essential Hypertension (0954A-323)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2005-09-01","conditions":"Hypertension","enrollment":62},{"nctId":"NCT00157963","phase":"PHASE4","title":"Hydrochlorothiazide (+) Losartan Potassium vs. Amlodipine Comparative Study (0954A-314)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2005-02-05","conditions":"Essential Hypertension","enrollment":174},{"nctId":"NCT00541684","phase":"PHASE3","title":"Health Assessment Study (0954-946)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2001-07-11","conditions":"Hypertension","enrollment":143},{"nctId":"NCT00449111","phase":"PHASE3","title":"An Open Label Study to Assess the Efficacy, Safety and Tolerability of COZAAR Plus (Losartan Potassium 50mg/Hydrochlorothiazide 12.5mg) Possibly Titrated up to COZAAR Plus-F (Losartan Potassium 100mg/Hydrochlorothiazide 25mg) in Patients With Essential Hypertension (0954A-325)","status":"TERMINATED","sponsor":"Organon and Co","startDate":"2006-03-13","conditions":"Hypertension","enrollment":11},{"nctId":"NCT00140959","phase":"PHASE4","title":"Losartan and HCTZ and Amlodipine vs Atenolol and Amlodipine (0954A-309)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2003-02-01","conditions":"Hypertension","enrollment":120},{"nctId":"NCT06539806","phase":"NA","title":"Clinical Study Evaluating the Effect of Losartan","status":"RECRUITING","sponsor":"Tanta University","startDate":"2024-07-20","conditions":"Pancreatic Cancer","enrollment":90},{"nctId":"NCT04335123","phase":"PHASE1","title":"Study of Open Label Losartan in COVID-19","status":"COMPLETED","sponsor":"University of Kansas Medical Center","startDate":"2020-04-04","conditions":"COVID-19","enrollment":34},{"nctId":"NCT06515678","phase":"","title":"Impact of Antihypertensive Therapy on Recurrence Risk of Ovarian Cancer for Bevacizumab-associated Hypertension","status":"ACTIVE_NOT_RECRUITING","sponsor":"Groupe Hospitalier Pitie-Salpetriere","startDate":"2024-05-20","conditions":"Ovarian Cancer, Antiangiogenic-Associated Hypertension, Adjuvant Bevacizumab","enrollment":9464},{"nctId":"NCT05479097","phase":"NA","title":"Feasibility Study of a Novel mHealth Application to Enable Community Health Workers to Manage","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2023-02-06","conditions":"Hypertension","enrollment":32},{"nctId":"NCT02735707","phase":"PHASE3","title":"Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia","status":"RECRUITING","sponsor":"UMC Utrecht","startDate":"2016-04-11","conditions":"Community-acquired Pneumonia, Influenza, COVID-19","enrollment":20000},{"nctId":"NCT06491940","phase":"NA","title":"Comparison of the Role of Losartan Alone vs Hydrochlorothiazide Plus Losartan","status":"NOT_YET_RECRUITING","sponsor":"RESnTEC, Institute of Research","startDate":"2024-08-01","conditions":"Proteinuria","enrollment":234},{"nctId":"NCT04643691","phase":"PHASE2","title":"Losartan and Spironolactone Treatment for ICU Patients With COVID-19 Suffering From ARDS","status":"TERMINATED","sponsor":"Assistance Publique Hopitaux De Marseille","startDate":"2020-09-11","conditions":"COVID-19, ARDS","enrollment":78},{"nctId":"NCT01277822","phase":"PHASE4","title":"Efficacy of Losartan + Amlodipine Compared to Amlodipine Alone in the Treatment of Uncontrolled High Blood Pressure (MK-0954F-399)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2011-05-30","conditions":"Hypertension","enrollment":334},{"nctId":"NCT00756938","phase":"PHASE3","title":"Study of Losartan in Pediatric Patients With Hypertension (MK-0954-337)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2009-03-01","conditions":"Hypertension","enrollment":101},{"nctId":"NCT00447603","phase":"PHASE3","title":"A Study of Losartan Compared to Losartan/HCTZ in Pediatric Patients With Hypertension (0954A-327)","status":"TERMINATED","sponsor":"Organon and Co","startDate":"2007-05-24","conditions":"Hypertension","enrollment":40},{"nctId":"NCT06366386","phase":"","title":"Integrating Hypertension Management in DSD for HIV","status":"NOT_YET_RECRUITING","sponsor":"Infectious Diseases Research Collaboration, Uganda","startDate":"2024-06-15","conditions":"Hypertension, HIV","enrollment":1100},{"nctId":"NCT06431477","phase":"PHASE4","title":"Efficacy and Safety of Telmisartan Compared With Losartan","status":"RECRUITING","sponsor":"Chong Kun Dang Pharmaceutical","startDate":"2023-04-19","conditions":"Diabetic Nephropathies, Hypertension","enrollment":98},{"nctId":"NCT00568178","phase":"PHASE3","title":"An Extension Study Designed to Assess Effects of Losartan on Proteinuria in Pediatric Populations (MK-0954-326 AM1,EXT1(AM2))","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2007-06-01","conditions":"Proteinuria","enrollment":306},{"nctId":"NCT00496834","phase":"PHASE4","title":"LAAS (Losartan Anti-Atherosclerosis Study)(0954-330)(COMPLETED)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2008-02-01","conditions":"Hypertension","enrollment":201},{"nctId":"NCT01431508","phase":"PHASE4","title":"A Study of Safety and Efficacy in MK-0954A Combination in Participants With Hypertension (MK-0954A-373 AM3)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2007-08-01","conditions":"Hypertension","enrollment":15},{"nctId":"NCT01307046","phase":"PHASE3","title":"MK-0954A in Japanese Patients With Essential Hypertension Not Adequately Controlled With Losartan (MK-0954A-352)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2011-03-29","conditions":"Hypertension","enrollment":336},{"nctId":"NCT01307033","phase":"PHASE3","title":"A Long-term Study of the Safety of MK-0954A in Patients With Essential Hypertension (MK-0954A-351)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2011-03-29","conditions":"Hypertension","enrollment":278},{"nctId":"NCT00546052","phase":"PHASE3","title":"A 52 Week Study to Evaluate the Effects of Losartan With or Without HCTZ on Plasma Glucose, Metabolic Parameters, Blood Pressure in Hypertensive Patients With Metabolic Syndrome (0954A-331)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2005-09-01","conditions":"Hypertension, Metabolic Disorder","enrollment":1738},{"nctId":"NCT00546754","phase":"PHASE3","title":"BP-EASE -Effectiveness of Losartan 50 mg/Hydrochlorothiazide (HCTZ) 12.5 mg Versus Valsartan 80 mg/HCTZ 12.5 mg Titrated as Needed in Patients With Essential Hypertension Not Controlled on Monotherapy (0954A-333)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2007-05-01","conditions":"Hypertension","enrollment":808},{"nctId":"NCT00739674","phase":"PHASE3","title":"SAALT: Subtracting Salt and Adding Losartan Trial (0954A-335)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2008-02-01","conditions":"Hypertension","enrollment":992},{"nctId":"NCT00090259","phase":"PHASE3","title":"Study to Evaluate Potential Decrease in Hospitalization Events, Time Between Events, and Increasing Longevity in Patients With Symptomatic Heart Failure (0954-948)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2001-12-19","conditions":"Heart Failure","enrollment":3834},{"nctId":"NCT02676466","phase":"PHASE2","title":"The ENRGISE (ENabling Reduction of Low-Grade Inflammation in SEniors) Pilot Study","status":"COMPLETED","sponsor":"University of Florida","startDate":"2016-04-26","conditions":"Inflammation","enrollment":289},{"nctId":"NCT02263729","phase":"PHASE1, PHASE2","title":"Phase 1/2 Prospective Double-Blind Placebo-Controlled Randomized Clinical Trial of Losartan to Treat Grade II & III Hamstring Strains","status":"TERMINATED","sponsor":"James J. Irrgang","startDate":"2016-08-10","conditions":"Hamstring Injury","enrollment":8},{"nctId":"NCT04815902","phase":"PHASE1, PHASE2","title":"Use of Senolytic and Anti-Fibrotic Agents to Improve the Beneficial Effect of Bone Marrow Stem Cells for Osteoarthritis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Steadman Philippon Research Institute","startDate":"2021-05-18","conditions":"Osteoarthritis, Knee","enrollment":100},{"nctId":"NCT05025956","phase":"PHASE1, PHASE2","title":"Senolytic Agent Improve the Benefit of Platelet-Rich Plasma and Losartan","status":"ACTIVE_NOT_RECRUITING","sponsor":"Steadman Philippon Research Institute","startDate":"2021-10-24","conditions":"Femoroacetabular Impingement","enrollment":68},{"nctId":"NCT06329076","phase":"NA","title":"Losartan Modulates Neural Responses to Looming Visual Stimuli: An Eye-tracking Study","status":"RECRUITING","sponsor":"University of Electronic Science and Technology of China","startDate":"2024-03-05","conditions":"Healthy","enrollment":80},{"nctId":"NCT06329050","phase":"NA","title":"The Effects of Losartan on Attention Control: An Eye-tracking Study","status":"RECRUITING","sponsor":"University of Electronic Science and Technology of China","startDate":"2024-03-05","conditions":"Healthy","enrollment":80},{"nctId":"NCT06344247","phase":"NA","title":"Comparison of the Efficacy and Safety of SGLT2i and GLP-1 Receptor Agonists in Obese Patients With Kidney Disease","status":"RECRUITING","sponsor":"RenJi Hospital","startDate":"2023-09-01","conditions":"Obesity, Chronic Kidney Diseases","enrollment":48},{"nctId":"NCT02373241","phase":"PHASE2","title":"Preventing Sickle Cell Kidney Disease","status":"TERMINATED","sponsor":"University of Alabama at Birmingham","startDate":"2015-04","conditions":"Anemia, Sickle Cell, Sickle Cell Disease, Kidney Disease","enrollment":1},{"nctId":"NCT06108063","phase":"PHASE1, PHASE2","title":"Mitigation of Arthrofibrosis After Total Knee Arthroplasty Using Losartan","status":"RECRUITING","sponsor":"Steadman Philippon Research Institute","startDate":"2024-03-06","conditions":"Knee Arthroplasty, Total","enrollment":120},{"nctId":"NCT03878524","phase":"PHASE1","title":"Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial","status":"TERMINATED","sponsor":"OHSU Knight Cancer Institute","startDate":"2020-04-01","conditions":"Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Anatomic Stage IV Breast Cancer AJCC v8, Anemia","enrollment":2},{"nctId":"NCT00456963","phase":"PHASE4","title":"Prevention of Diabetes and Hypertension","status":"TERMINATED","sponsor":"Istituto Auxologico Italiano","startDate":"2007-09","conditions":"Diabetes Mellitus, Hypertension","enrollment":3000},{"nctId":"NCT05607017","phase":"EARLY_PHASE1","title":"Losartan in Prevention of Radiation-Induced Heart Failure","status":"UNKNOWN","sponsor":"Massachusetts General Hospital","startDate":"2024-01-01","conditions":"Breast Cancer, Myocardial Fibrosis, Radiation-Induced Fibrosis","enrollment":10},{"nctId":"NCT00168857","phase":"PHASE4","title":"A Prospective, Randomised, Double-blind, Double-dummy, Forced-titration, Multicentre, Parallel Group, One Year Treatment Trial to Compare Telmisartan (MICARDIS) 80 mg Versus Losartan (COZAAR) 100 mg, in Hypertensive Type 2 Diabetic Patients With Overt Nephropathy (AMADEO Study)","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2003-07-09","conditions":"Hypertension, Diabetic Nephropathies","enrollment":860}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"losartan (drug)","genericName":"losartan (drug)","companyName":"Odense University Hospital","companyId":"odense-university-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Losartan blocks angiotensin II receptors on blood vessels and tissues, preventing vasoconstriction and reducing blood pressure. Used for Hypertension, Heart failure with reduced ejection fraction, Diabetic nephropathy in patients with type 2 diabetes.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}